Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Cancer Research
|
June 25, 1992
Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues
S D Weitman, R H Lark, L R Coney, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 31, 1997
Chimeric bispecific OC/TR monoclonal antibody mediates lysis of tumor cells expressing the folate-binding protein (MOv18) and displays decreased immunogenicity in patients
R M Luiten, S O Warnaar, D Sanborn, et al.
European Journal of Immunology
|
November 11, 1999
Comparison of IgE and IgG antibody-dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma
H J Gould, G A Mackay, S N Karagiannis, et al.
The Journal of Infectious Diseases
|
July 4, 1998
First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response
R R MacGregor, J D Boyer, K E Ugen, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Cancer Research
|
June 25, 1992
Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues
S D Weitman, R H Lark, L R Coney, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 31, 1997
Chimeric bispecific OC/TR monoclonal antibody mediates lysis of tumor cells expressing the folate-binding protein (MOv18) and displays decreased immunogenicity in patients
R M Luiten, S O Warnaar, D Sanborn, et al.
European Journal of Immunology
|
November 11, 1999
Comparison of IgE and IgG antibody-dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma
H J Gould, G A Mackay, S N Karagiannis, et al.
The Journal of Infectious Diseases
|
July 4, 1998
First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response
R R MacGregor, J D Boyer, K E Ugen, et al.
Page
of 2